Jan Tijssen

Showing 1-13 of 13 articles

Coronary interventions

Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final 5-Year Results of the AIDA Randomized Clinical Trial

Kerkmeijer L, Renkens MP, Tijssen RY, Hofma S, van der Schaaf R, Arkenbout E, Weevers AP, Garcia-Garcia H, Kraak R, Piek J, Tijssen J, Henriques J, de Winter R, Wykrzykowska J

August 31, 2021 | 10.4244/EIJ-D-21-00419

Coronary interventions

Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial

Kraak R, Tijssen R, van Dongen I, Elias J, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Tijssen J, Piek J, de Winter R, Henriques J, Wykrzykowska J

December 4, 2020 | 10.4244/EIJ-D-18-00884

Coronary interventions

Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

October 23, 2020 | 10.4244/EIJ-D-19-00498

Coronary interventions

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial

Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R

October 23, 2020 | 10.4244/EIJ-D-19-01079

Coronary interventions

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabaté M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg P, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

April 3, 2020 | 10.4244/EIJ-D-19-00699

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial

Kerkmeijer L, Tijssen RY, Hofma S, van der Schaaf R, Arkenbout K, Kraak R, Weevers A, Piek J, de Winter R, Tijssen J, Henriques J, Wykrzykowska J, Ijsselmuiden A, Kauer F, Beijk M, Vis M, Koch K

September 20, 2019 | 10.4244/EIJ-D-19-00325

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI

Tijssen RY, Kraak R, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Elias J, van Dongen I, Koch K, Baan Jr J, Vis M, de Winter R, Piek J, Tijssen J, Henriques J, Wykrzykowska J

July 20, 2018 | 10.4244/EIJ-D-18-00335

Coronary interventions

Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial

Tijssen RY, Kraak R, Elias J, van Dongen I, Kalkman D, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek J, Henriques J, de Winter R, Tijssen J, Onuma Y, Serruys P, Wykrzykowska J

July 20, 2018 | 10.4244/EIJ-D-17-01152

Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease

Abdelghani M, Cavalcante R, Miyazaki Y, de Winter R, Tijssen J, Sarmento-Leite R, Mangione J, Abizaid A, Lemos P, Serruys P, de Brito Jr F

November 20, 2017 | 10.4244/EIJ-D-17-00328

Coronary interventions

Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial

Teeuwen K, Spoormans E, Bennett J, Dubois C, Desmet W, Ughi G, Belmans A, Kelder J, Tijssen J, Agostoni P, Suttorp MJ, Adrianssens T

August 4, 2017 | 10.4244/EIJ-D-17-00261

Coronary interventions

Microvascular dysfunction following ST-elevation myocardial infarction and its recovery over time

Hassell M, Bax M, van Lavieren M, Nijveldt R, Hirsch A, Robbers L, Marques K, Tijssen J, Zijlstra F, van Rossum A, Delewi R, Piek J

August 4, 2017 | 10.4244/EIJ-D-16-00818

Coronary interventions

Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial

Milojevic M, Head S, Andrinopoulou E, Serruys P, Mohr F, Tijssen J, Kappetein A

May 15, 2017 | 10.4244/EIJ-D-16-00745

Latest news

NEW ISSUE

State-of-the-Art on Glucose Management, Diabetes and PCI; a Mini Focus on CTOs and more...

October 1, 2021

AHEAD OF PRINT

The FAST II study

Kaneshka Masdjedi et al.

October 14, 2021

AHEAD OF PRINT

OCT-guided PCI in iatrogenic artery stenosis

Zvonimir Ostojic et al.

October 14, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

AHEAD OF PRINT

Transfemoral transcatheter tricuspid valve replacement after failed leaflet repair

Mirjam G. Wild et al.

October 14, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.

October 1, 2021

AHEAD OF PRINT

Predictors of rotational atherectomy

Sean Fitzgerald et al.